Liverpool

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• GlaxoSmithKline4 trials

Running trials

• Active, not recruiting

  Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT04246047· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT04162210· Phase 3· GlaxoSmithKline· Source

Closed trials

• Recruiting

  A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  NCT05878717· Phase 2/3· GlaxoSmithKline· Source

• Completed

  Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

  NCT05064358· Phase 2· GlaxoSmithKline· Source